Central European Journal of Immunology (Oct 2017)

Interference RNA in immune-mediated oral diseases – minireview

  • Raghu Dhanapal,
  • Sreepallavi Somasundarapandian,
  • Sosroseno Wihaskoro,
  • Ranganathan Kannan,
  • Govind Rajkumar,
  • Ramasamy Chidambaram

DOI
https://doi.org/10.5114/ceji.2017.70974
Journal volume & issue
Vol. 42, no. 3
pp. 301 – 304

Abstract

Read online

Immune-mediated oral disorders are characterised by their chronicity, and some are refractory to treatment. Interference RNA (iRNA) has been implicated in the underlying mechanism of such immune-mediate oral and refractory inflammatory oral diseases. iRNA-based understanding of the mechanism in these diseases may help to produce non-invasive diagnostic methodologies and treatment modalities of such drug non-responsive diseases. Oral lesions in these immune-mediated diseases can precede the occurrence of lesions in other regions of the body. The early diagnosis and treatment of these drug non-responsive diseases might benefit the patient by reducing chronicity and probably even resolving the disease. This aim of the present minireview is to give an overview of the possible implications of iRNA on the pathogenesis, diagnosis, and treatments of immune-mediated and inflammatory oral diseases. The manuscript can form the framework for research on iRNA in these immune-mediated oral disorders.

Keywords